Gelatin-based nanoparticles and antibiotics: a new therapeutic approach for osteomyelitis?
Ali Sherafati Chaleshtori,
No information about this author
Zeynab Marzhoseyni,
No information about this author
Nikoo Saeedi
No information about this author
et al.
Frontiers in Molecular Biosciences,
Journal Year:
2024,
Volume and Issue:
11
Published: July 30, 2024
The
result
of
infection
bone
with
microorganisms
is
osteomyelitis
and
septic
arthritis.
Methicillin-resistant
Staphylococcus
aureus
(MRSA)
responsible
for
most
its
cases
(more
than
50%).
Since
MRSA
resistant
to
many
treatments,
it
accompanied
by
high
costs
numerous
complications,
necessitating
more
effective
new
treatments.
Recently,
development
gelatin
nanoparticles
have
attracted
the
attention
scientists
biomedicine
itself,
been
utilized
as
a
delivery
vehicle
antibiotics
because
their
biocompatibility,
biodegradability,
cost-effectiveness.
Promising
results
reported
modification
combinations
chemical
agents.
Although
these
findings
suggested
that
has
potential
be
suitable
option
continuous
release
in
arthritis
treatment,
they
still
not
become
routine
clinical
practices.
deliver
antibiotic
using
gelatin-derived
composites
vancomycin
which
showed
good
efficacy.
To
date,
number
pre-clinical
studies
evaluated
utility
gelatin-based
management
osteomyelitis.
Gelatin-based
were
found
satisfactory
performance
control
infection,
well
promotion
defect
repair
chronic
models.
This
review
summarized
available
evidence
provides
insight
into
controlled
antibiotics.
Language: Английский
Progress in the role of nanoparticles in the diagnosis and treatment of bone and joint tuberculosis
Yitong Ding,
No information about this author
B P Li,
No information about this author
Yangfei Yi
No information about this author
et al.
Frontiers in Medicine,
Journal Year:
2025,
Volume and Issue:
12
Published: Jan. 24, 2025
Bone
and
joint
tuberculosis
(BJTB),
caused
by
Mycobacterium
(MTB),
is
a
prevalent
form
of
extrapulmonary
that
poses
significant
challenges
to
global
public
health
due
difficulties
in
early
diagnosis,
prolonged
treatment
cycles,
drug
resistance.
Recent
advancements
nanotechnology
have
introduced
novel
solutions
for
the
detection
precise
BJTB,
leveraging
unique
physicochemical
properties
such
as
high
specific
surface
area,
targeted
delivery
capabilities,
sustained
release,
excellent
biocompatibility.
In
diagnostic
applications,
nanomaterials
markedly
enhance
sensitivity
accuracy
methods
while
reducing
testing
time.
These
technologies
are
adaptable
resource-limited
settings,
enabling
earlier
patient
intervention
mitigating
disease
progression
risk.
therapeutic
prolong
retention
bone
tissue
through
delivery,
thereby
decreasing
medication
frequency
minimizing
toxic
side
effects,
which
significantly
improves
efficacy.
Despite
substantial
progress,
further
research
required
address
long-term
safety
concerns,
broaden
clinical
applicability,
evaluate
performance
under
complex
pathological
conditions.
This
review
summarizes
recent
diagnosing
treating
BJTB
identifies
key
areas
future
research,
laying
groundwork
advancing
precision
medicine
personalized
treatments.
Language: Английский
Advances in spray drying technology for anti-tubercular formulation development: A comprehensive review
Drying Technology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 37
Published: Jan. 27, 2025
Language: Английский
Enhanced Antibacterial Efficacy of Bioceramic Implants Functionalized with Ciprofloxacin: An In Silico and In Vitro Study
Pharmaceutics,
Journal Year:
2024,
Volume and Issue:
16(8), P. 998 - 998
Published: July 28, 2024
This
study
explores
the
antibacterial
efficacy
and
cytotoxicity
of
ciprofloxacin-functionalized
bioceramic
implants.
We
synthesized
hydroxyapatite-ciprofloxacin
(HACPXCS)
composites
applied
them
to
titanium
substrates
(Ti-HA-CPX),
evaluating
their
performance
in
vitro
against
Staphylococcus
aureus
(ATCC
25923)
Escherichia
coli
25922).
Antibacterial
activity
was
assessed
using
Kirby-Bauer
disc
diffusion
method,
while
tested
mesenchymal
stem
cells.
The
results
demonstrated
that
Ti-HA-CPX
exhibited
superior
activity,
with
inhibition
zones
33.5
mm
(MIC
0.5
µg/mL)
for
27.5
0.25
However,
showed
moderate
(80%
cell
viability).
HACPXCS
composites,
whether
chemically
or
mechanically
mixed
(HACPXMM),
also
displayed
significant
but
ranging
from
low
levels.
Molecular
docking
studies
confirmed
strong
binding
affinities
between
ciprofloxacin
bacterial
proteins,
correlating
enhanced
efficacy.
These
findings
suggest
offer
a
promising
approach
single-stage
surgical
interventions
treating
chronic
osteomyelitis
infected
fractures,
balancing
effectiveness
manageable
cytotoxicity.
Language: Английский